Logo image of CBAH

CBRE ACQUISITION HOLDINGS-A (CBAH) Stock Fundamental Analysis

NYSE:CBAH - New York Stock Exchange, Inc. - Common Stock

10.75  +0.65 (+6.44%)

After market: 10.94 +0.19 (+1.77%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CBAH. CBAH was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CBAH have multiple concerns. CBAH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CBAH had negative earnings in the past year.
CBAH Yearly Net Income VS EBIT VS OCF VS FCFCBAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -0.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBAH Yearly ROA, ROE, ROICCBAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 -0.02 -0.04 -0.06 -0.08

1.3 Margins

CBAH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBAH Yearly Profit, Operating, Gross MarginsCBAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020

More info and screens

2

2. Health

2.1 Basic Checks

CBAH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBAH Yearly Shares OutstandingCBAH Yearly Shares OutstandingYearly Shares Outstanding 2020 10M 20M 30M 40M
CBAH Yearly Total Debt VS Total AssetsCBAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 100M 200M 300M 400M

2.2 Solvency

CBAH has an Altman-Z score of 6.83. This indicates that CBAH is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that CBAH is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 6.83
ROIC/WACCN/A
WACCN/A
CBAH Yearly LT Debt VS Equity VS FCFCBAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.47 indicates that CBAH may have some problems paying its short term obligations.
CBAH has a Quick Ratio of 0.47. This is a bad value and indicates that CBAH is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
CBAH Yearly Current Assets VS Current LiabilitesCBAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 129.47% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-43.68%
EPS Next 2Y-107.62%
EPS Next 3Y129.31%
EPS Next 5Y129.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBAH Yearly EPS VS EstimatesCBAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CBAH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CBAH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBAH Price Earnings VS Forward Price EarningsCBAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBAH Per share dataCBAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as CBAH's earnings are expected to grow with 129.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-107.62%
EPS Next 3Y129.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBAH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CBRE ACQUISITION HOLDINGS-A

NYSE:CBAH (12/9/2021, 8:15:12 PM)

After market: 10.94 +0.19 (+1.77%)

10.75

+0.65 (+6.44%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners71.77%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap454.32M
Analysts100
Price Target14.28 (32.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS8.65
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 6.83
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-43.68%
EPS Next 2Y-107.62%
EPS Next 3Y129.31%
EPS Next 5Y129.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A